Isosorbide Mononitrate Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

The process starts by converting sorbitol into isosorbide, which then undergoes nitration with nitric acid in the presence of acetic anhydride and acetic acid. The reaction mixture is then subjected to crystallization and filtration to isolate the crude product, followed by purification and drying to obtain pharmaceutical-grade isosorbide mononitrate.

Raw material and reagent sourcing, including high-purity sorbitol and nitrating agents, represents the largest part of operating expenses. The main cost requirements include sorbitol, nitric acid, acetic anhydride, acetic acid, solvents, and other processing inputs used during synthesis and purification. These raw materials and reagents can account for around 50 to 65% of total raw material costs, with sorbitol and nitrating agents representing a significant share due to their purity requirements and consumption levels.

The capital cost includes glass-lined nitration reactors, crystallization units, industrial centrifuges, filtration systems, solvent recovery units, and quality control laboratory equipment. These systems form a major part of the process-related capital investment required for the plant and are estimated to account for around 45 to 55% of total capital cost, depending on plant scale, equipment specifications, automation, and purification requirements.

Raw material and reagent sourcing, particularly high-purity sorbitol and nitrating agents, is a major operating cost. Other cost drivers include energy and utilities for heating and cooling cycles, skilled labor, regulatory compliance, equipment maintenance, and the specialized equipment required for handling corrosive materials.

Isosorbide mononitrate is produced in pharmaceutical grade for use in cardiovascular medicines. The manufacturing process includes purification and quality-control steps to meet pharmaceutical purity and quality requirements.

Manufacturing requires compliance with applicable pharmaceutical quality and safety standards, including GMP requirements, validated production processes, quality-control testing, documentation, and facility certifications. Regulatory requirements such as FDA, EMA, or DMF filings depend on the intended market and product registration requirements.